RECRUITING

Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

Talk to us

Conditions

Prostate CancerProstate biopsyinherited risk assessmentPSA

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment

Official Title

Observational and Prospective Study on the Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy (GenBx)

Quick Facts

Study Start:2021-12-13
Study Completion:2025-12-13
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05295407

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 69 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Consecutive patients undergoing prostate biopsy for detection of prostate cancer
  2. * Aged 40 to 69 years
  3. * Four ethnicity groups (Caucasian, African Americans, East Asians, Latinos)
  4. * PSA between 2.5-10 ng/mL
  1. * Previous diagnosis of prostate cancer.
  2. * Ethnicity outside the inclusion criterion (including mixed ethnicity).
  3. * Any prior PSA test result outside the range of inclusion criterion.

Contacts and Locations

Study Contact

Annie Ashworth
CONTACT
2243647502
aashworth@northshore.org

Principal Investigator

Jianfeng Xu, MD, Dr.PH
PRINCIPAL_INVESTIGATOR
NorthShore University HealthSystem

Study Locations (Sites)

NorthShore University HealthSystem
Evanston, Illinois, 60626
United States

Collaborators and Investigators

Sponsor: NorthShore University HealthSystem

  • Jianfeng Xu, MD, Dr.PH, PRINCIPAL_INVESTIGATOR, NorthShore University HealthSystem

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-12-13
Study Completion Date2025-12-13

Study Record Updates

Study Start Date2021-12-13
Study Completion Date2025-12-13

Terms related to this study

Keywords Provided by Researchers

  • Prostate biopsy
  • prostate cancer
  • inherited risk assessment
  • PSA

Additional Relevant MeSH Terms

  • Prostate Cancer